Cite
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry
MLA
Cremer, Sebastian, et al. Elevated Markers of Thrombo-Inflammatory Activation Predict Outcome in Patients with Cardiovascular Comorbidities and COVID-19 Disease: Insights from the LEOSS Registry. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1238104266&authtype=sso&custid=ns315887. Accessed 5 Jan. 2025.
APA
Cremer, S., Jakob, C., Berkowitsch, A., Borgmann, S., Pilgram, L., Tometten, L., Classen, A., Wille, K., Weidlich, S., Gruener, B., Dimmeler, S., Massberg, S., Rieg, S., & Zeiher, A. M. (n.d.). Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry.
Chicago
Cremer, Sebastian, Carolin Jakob, Alexander Berkowitsch, Stefan Borgmann, Lisa Pilgram, Lukas Tometten, Annika Classen, et al. 2025. “Elevated Markers of Thrombo-Inflammatory Activation Predict Outcome in Patients with Cardiovascular Comorbidities and COVID-19 Disease: Insights from the LEOSS Registry.” Accessed January 5. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1238104266&authtype=sso&custid=ns315887.